Fmr LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,880 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,880

Previous 1,792,350 99.73%

Holding current value

Previous $75.8 Million 99.74%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$38.96 - $42.75 $69.6 Million - $76.4 Million	-1,787,470 Reduced 99.73%	4,880 $199,000
Q1 2024 May 13, 2024	SELL	$40.88 - $43.27 $323 Million - $342 Million	-7,899,501 Reduced 81.51%	1,792,350 $75.8 Million
Q4 2023 Feb 13, 2024	SELL	$20.27 - $42.44 $282 Million - $591 Million	-13,931,293 Reduced 58.97%	9,691,851 $411 Million
Q3 2023 Nov 13, 2023	BUY	$20.26 - $31.91 $2.62 Million - $4.13 Million	129,355 Added 0.55%	23,623,144 $516 Million
Q2 2023 Aug 11, 2023	BUY	$23.9 - $35.38 $634,090 - $938,666	26,531 Added 0.11%	23,493,789 $747 Million
Q1 2023 May 11, 2023	BUY	$22.82 - $35.32 $1.14 Million - $1.77 Million	50,126 Added 0.21%	23,467,258 $572 Million
Q4 2022 Feb 13, 2023	BUY	$25.35 - $31.96 $2.57 Million - $3.25 Million	101,567 Added 0.44%	23,417,132 $739 Million
Q3 2022 Nov 10, 2022	BUY	$25.5 - $41.42 $27.3 Million - $44.4 Million	1,072,181 Added 4.82%	23,315,565 $659 Million
Q2 2022 Aug 12, 2022	BUY	$20.62 - $37.15 $812,077 - $1.46 Million	39,383 Added 0.18%	22,243,384 $588 Million
Q1 2022 May 13, 2022	BUY	$23.5 - $35.38 $63.3 Million - $95.3 Million	2,694,188 Added 13.81%	22,204,001 $777 Million
Q4 2021 Feb 14, 2022	BUY	$29.21 - $44.64 $20.5 Million - $31.4 Million	703,184 Added 3.74%	19,509,813 $633 Million
Q3 2021 Nov 15, 2021	BUY	$21.26 - $38.85 $212 Million - $387 Million	9,969,568 Added 112.82%	18,806,629 $555 Million
Q2 2021 Aug 13, 2021	BUY	$12.56 - $29.69 $111 Million - $262 Million	8,837,061 New	8,837,061 $226 Million

Others Institutions Holding CERE

# of Institutions

269

Shares Held

155M

Call Options Held

2.19M

Put Options Held

3.92M

View Full List

About Cerevel Therapeutics Holdings, Inc.

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

More about CERE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account